Abstract
The title compound, [Ru2(μ-O2CCH3)4(C5H4ClN)2]PF6·C2H4Cl2, was obtained via a rapid substitution reaction of 3-chloropyridine for water in [Ru2(μ-O2CCH3)4(H2O)2]PF6 in 2-propanol and subsequent crystallization from a dichloroethane solution. The cationic diruthenium(II,III) tetraacetate core lies on a crystallographic inversion center with Ru—Ru and Ru—N bond lengths of 2.2738 (3) and 2.2920 (17) Å, respectively. The Ru—Ru—N bond angle is close to linear at 176.48 (4)°, and a significant π-stacking interaction of 3.5649 (16) Å is seen between overlapping pyridine rings of adjacent cations.
Funder
Natural Sciences and Engineering Research Council of Canada
Publisher
International Union of Crystallography (IUCr)
Subject
Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,General Medicine
Reference13 articles.
1. Aquino, A. J., Cameron, T. S., Robertson, K. N. & Aquino, M. A. S. (2021). CCDC Communication (CCDC code2083050). CCDC, Cambridge, England. https://doi.org/10.5517/ccdc.csd.cc27xl5y
2. Hydrogen bonding in diruthenium(II,III) tetraacetate complexes with biologically relevant axial ligands
3. SIR2004: an improved tool for crystal structure determination and refinement
4. Tetra-μ-acetato-O:O′-bis(quinoline-N)diruthenium(II,III) hexafluorophosphate quinoline solvate
5. Higashi, T. (1995). ABSCOR. Rigaku Corporation, Tokyo, Japan.